U.S. Emerging Pulmonary Drug Delivery Technologies Markets

 

USD 2,450

* Required Fields

USD 2,450

PAY BY INVOICE

Be the first to review this product

This report analyzes the U.S. emerging pulmonary drug delivery technologies markets, for the forecast period 1999 to 2009. The report is segmented into 5 chapters viz. Executive Summary, Total Market, Non-CFC Metered Dose Inhalers Market, Dry Powder Inhalers Market and Liquid Based Inhalers Market. Each segment provides revenue forecasts, market share, pricing trends, demand analysis, competitive structure and market and technology trends. Drivers, restraints and challenges and the strategic recommendations are also discussed. The Market Engineering Awards are conferred on deserving companies.

Table of Contents

U.S. Emerging Pulmonary Drug Delivery Technologies Markets, Executive SummaryExecutive SummaryExecutive SummaryU.S. Emerging Pulmonary Drug Delivery Technologies Markets, Total MarketOverviewIntroductionMarket Engineering AnalysisForecasts and TrendsPhasing out of CFC MDIsDemand AnalysisPatient Forecasts by TechnologyPatient Forecasts by ApplicationPricing AnalysisRevenue ForecastsChallengesChallenges OverviewTechnological Inadequacies Threaten SurvivalPast Experiences Tarnish Future Prospects and Limit SuccessUnsure Product Approval Outcome Creates AmbiguityUnproven Efficacy and Safety in Newer Applications Creates UncertaintyOverzealous Technological Innovation Limits Success OddsMarket Engineering AwardsMarketing Strategy Leadership AwardGrowth Strategy Market Engineering AwardProduct Differentiation Innovation AwardCompetitive Strategy AwardU.S. Emerging Pulmonary Drug Delivery Technologies Markets, Non-CFC Metered Dose Inhalers MarketOverviewIntroductionMarket Engineering AnalysisMarket DriversMarket RestraintsCompetitive StructureForecast and TrendsPatient ForecastsPricing AnalysisRevenue ForecastsNon-CFC Metered Dose Inhalers Technology3M Drug Delivery SystemsAeropharm Technologies Inc.U.S. Emerging Pulmonary Drug Delivery Technologies Markets, Dry Powder Inhalers MarketOverviewIntroductionMarket Engineering AnalysisMarket DriversMarket RestraintsCompetitive StructureForecast and TrendsPatient ForecastsPricing AnalysisRevenue ForecastsMarket Share AnalysisDry Powder Inhalers by ApplicationDry Powder Inhalers in Asthma/COPDDry Powder Inhalers in Cystic FibrosisDry Powder Inhalers in DiabetesDry Powder Inhalers in CancerDry Powder Inhalers in MigraineDry Powder Inhaler TechnologiesAlkermesInhale TherapeuticsMicrodose TechnologiesOriel TherapeuticsRespiricsSkye PharmaU.S. Emerging Pulmonary Drug Delivery Technologies Markets, Liquid-Based Inhalers MarketOverviewIntroductionMarket Engineering AnalysisMarket DriversMarket RestraintsCompetitive StructureForecast and TrendsPatient ForecastsPricing AnalysisRevenue ForecastsLiquid-Based Inhalers by ApplicationLiquid-Based Inhalers in Asthma/COPDLiquid-Based Inhalers in Cystic FibrosisLiquid-Based Inhalers in DiabetesLiquid-Based Inhalers in CancerLiquid-Based Inhaler TechnologiesBattelle PharmaAradigm CorporationAerogen




Related Research

Release Date : 26-Sep-17

Region : North America

Release Date : 25-Sep-17

Region : North America

Release Date : 19-Sep-17

Region : North America

Release Date : 08-Sep-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.